Hope on the horizon for preeclampsia with experimental drug DM199
In a South African hospital, researchers testing the experimental drug DM199 saw blood-pressure stabilization in pregnant women with preeclampsia after escalating doses, with the treatment not appearing to cross the placenta or breast milk and possibly improving placental blood flow. While early and based on small groups, the results offer cautious optimism for a first pharmaceutical therapy that could help mothers stay pregnant longer and protect babies, pending larger studies.